Dr. Idos on Remaining Questions With Multiplex Panel Testing

Gregory E. Idos, MD
Published: Tuesday, Sep 27, 2016



Gregory E. Idos, MD, assistant professor of Clinical Medicine, Department of Surgery, Division of Colorectal Surgery, Keck School of Medicine of University of Southern California, sheds light on the cost effectiveness and other questions surrounding multiplex panel testing.

Currently, researchers are exploring the overall utility of how multiplex panel tests could potentially affect surgical management and chemotherapy prevention, Idos explains.

Regarding cost, using the gene-by-gene approach has been found to be more expensive than multiplex panel testing, he adds. Over the last few years, it has also been found that the cost of sequencing has gone down.
SELECTED
LANGUAGE


Gregory E. Idos, MD, assistant professor of Clinical Medicine, Department of Surgery, Division of Colorectal Surgery, Keck School of Medicine of University of Southern California, sheds light on the cost effectiveness and other questions surrounding multiplex panel testing.

Currently, researchers are exploring the overall utility of how multiplex panel tests could potentially affect surgical management and chemotherapy prevention, Idos explains.

Regarding cost, using the gene-by-gene approach has been found to be more expensive than multiplex panel testing, he adds. Over the last few years, it has also been found that the cost of sequencing has gone down.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Addressing Post-Transplant Obstacles: Current and Emerging Strategies to Evolve the Standard of Care for Patients With Graft-Versus-Host DiseaseMar 28, 20192.0
2017 Year in Review™: Clinical Impact of Immunotherapies in the Treatment of CancerMar 30, 20191.75
Publication Bottom Border
Border Publication
x